From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review
In tumor therapeutics, the transition from conventional cytotoxic drugs to targeted molecular therapies, such as those targeting receptor tyrosine kinases, has been pivotal. Despite this progress, the clinical...
Source: Journal of Experimental and Clinical Cancer Research - Category: Cancer & Oncology Authors: Moksada Regmi, Yingjie Wang, Weihai Liu, Yuwei Dai, Shikun Liu, Ke Ma, Guozhong Lin, Jun Yang, Hongyi Liu, Jian Wu and Chenlong Yang Tags: Review Source Type: research